201 related articles for article (PubMed ID: 37519166)
1. Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.
Fan Z; Liu X; Liu J; Chen C; Zhou M
J Integr Neurosci; 2023 Jun; 22(4):85. PubMed ID: 37519166
[TBL] [Abstract][Full Text] [Related]
2. Blood Neurofilament Light Chain in Different Types of Dementia.
Gu L; Shu H; Wang Y; Wang P
Curr Alzheimer Res; 2023; 20(3):149-160. PubMed ID: 37264656
[TBL] [Abstract][Full Text] [Related]
3. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
[TBL] [Abstract][Full Text] [Related]
4. Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum.
Lehmann S; Schraen-Maschke S; Vidal JS; Blanc F; Paquet C; Allinquant B; Bombois S; Gabelle A; Delaby C; Hanon O;
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139190
[TBL] [Abstract][Full Text] [Related]
5. SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis.
Sahrai H; Norouzi A; Hamzehzadeh S; Majdi A; Kahfi-Ghaneh R; Sadigh-Eteghad S
BMC Neurol; 2023 Sep; 23(1):331. PubMed ID: 37723414
[TBL] [Abstract][Full Text] [Related]
6. Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study.
Mazzeo S; Ingannato A; Giacomucci G; Manganelli A; Moschini V; Balestrini J; Cavaliere A; Morinelli C; Galdo G; Emiliani F; Piazzesi D; Crucitti C; Frigerio D; Polito C; Berti V; Bagnoli S; Padiglioni S; Sorbi S; Nacmias B; Bessi V
Eur J Neurol; 2024 Jan; 31(1):e16089. PubMed ID: 37797300
[TBL] [Abstract][Full Text] [Related]
7. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
8. Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer's Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study.
Shim Y
Curr Alzheimer Res; 2023; 20(10):715-724. PubMed ID: 38299421
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: A systematic review and meta-analysis.
Zhang J; Cheng H; Liu W; Li H; Song Y; Jia L
Medicine (Baltimore); 2022 Mar; 101(9):e28932. PubMed ID: 35244049
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
Li J; Yang M; Wei R; Cao Y; Fan X; Zhang S
J Alzheimers Dis; 2024; 97(4):1589-1620. PubMed ID: 38306045
[TBL] [Abstract][Full Text] [Related]
11. Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment.
Liu W; Lin H; He X; Chen L; Dai Y; Jia W; Xue X; Tao J; Chen L
Transl Psychiatry; 2020 Apr; 10(1):125. PubMed ID: 32350238
[TBL] [Abstract][Full Text] [Related]
12. Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment.
Jing X; Wang L; Song M; Geng H; Li W; Huo Y; Huang A; Wang X; An C
Sci Rep; 2024 Apr; 14(1):9072. PubMed ID: 38643230
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
Vrillon A; Ashton NJ; Karikari TK; Götze K; Cognat E; Dumurgier J; Lilamand M; Zetterberg H; Blennow K; Paquet C
J Neurol; 2024 Mar; 271(3):1297-1310. PubMed ID: 37950758
[TBL] [Abstract][Full Text] [Related]
14. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.
Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B
Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932
[TBL] [Abstract][Full Text] [Related]
15. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
16. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
17. Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
Götze K; Vrillon A; Bouaziz-Amar E; Mouton-Liger F; Hugon J; Martinet M; Dumurgier J; Cognat E; Zetterberg H; Blennow K; Hourrègue C; Paquet C; Lilamand M
Neurobiol Dis; 2023 Jan; 176():105937. PubMed ID: 36462720
[TBL] [Abstract][Full Text] [Related]
18. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
Lewczuk P; Ermann N; Andreasson U; Schultheis C; Podhorna J; Spitzer P; Maler JM; Kornhuber J; Blennow K; Zetterberg H
Alzheimers Res Ther; 2018 Jul; 10(1):71. PubMed ID: 30055655
[TBL] [Abstract][Full Text] [Related]
19. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
[TBL] [Abstract][Full Text] [Related]
20. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
